LAUSR

Roche, Janssen, Takeda, MSD, Gilead, Bristol Myers Squibb, AstraZenecca; Research Funding: Celgene, Roche, Abbvie; Other Remuneration: Roche, Amgen. Chu, M: Honoraria: AstraZeneca, Gilead, Celgene. Dreyling, M: Honoraria: Bayer, Celgene, Gilead, Janssen, Roche, Acerta, Bayer, Celgene, Gilead, Janssen, Novartis, Roche, Sandoz; Research Funding: Celgene, Janssen, Mundipharma, Roche; Other Remuneration: Celgene, Janssen, Roche, Takeda. Goy, A: Consultant Advisory Role: Acerta Pharma, Celgene, Kite/Gilead, Pharmacyclics/J&J, and Takeda; Honoraria: Celgene, Pharmacyclics/J&J, and Takeda; Research Funding: Acerta Pharma, Celgene, Genentech, Kite/Gilead, Pharmacyclics/J&J, and Seattle Genetics; Other Remuneration: Acerta Pharma, Celgene, Pharmacyclics/J&J, and Takeda. Inwards, D: Research Funding: Acerta (site PI for current ACE-LY308 study). Jurczak, W: Consultant Advisory Role: Astra Zeneca, Gilead, Sandoz Novartis, Roche, Morphosys; Research Funding: Morphosys, Roche, Sandoz-Novarttis, Celtrione, Celgene, Janssen, Astra Zencea, Gilead, TG Therapeutics, Incyte, Bayer. Mayer, J: Research Funding: Acerta Pharma. Robak, T: Research Funding: Acerta Pharma, AstraZeneca. Yoon, S: Consultant Advisory Role: Amgen, Celgene, AbbVie, Astellas, Janssen, Pfizer, MSD; Research Funding: Genentech. Zinzani, P: Consultant Advisory Role: MSD, BMS, Servier, Janssen, Gilead; Honoraria: MSD, BMS, Servier, Janssen, Gilead. Yin, M: Employment Leadership Position: Acerta Pharma; Stock Ownership: Acerta Pharma. Chen, T: Employment Leadership Position: Acerta Pharma; Stock Ownership: Acerta Pharma.